Aptalis Pharma, Kyowa Hakko Kirin sales and marketing update

Aptalis launched Rectiv nitroglycerin 0.4% ointment in the U.S. to treat moderate to severe pain associated with chronic anal fissures. Kyowa's ProStrakan Group plc subsidiary granted Aptalis U.S. rights to Rectiv in January (see BioCentury, Jan. 16). ...